FIELD: medicine. SUBSTANCE: medicinal agent has enzyme hyaluronidase produced by strain Streptomyces actinocidus-77 and mannitol (0,09-0,11 g/300 IU enzyme activity). Agent shows the following advantages as compared with preparation ronidase: enhanced activity, solubility, bioavalability, high clinical efficacy. EFFECT: enhanced properties of agent. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
HYALURONIDASE AND METHOD OF ITS APPLICATION | 2012 |
|
RU2608492C2 |
PREPARATION FOR TREATMENT OF CONNECTIVE TISSUE PATHOLOGICAL STATE | 1997 |
|
RU2112542C1 |
METHOD FOR TREATMENT AND PROPHYLAXIS OF DEVELOPMENT OF HYPERTROPHIC AND KELOID SCARS | 2002 |
|
RU2220741C2 |
METHOD OF TREATMENT AND PREVENTION OF HYPERTROPHIC AND KELOIDAL SCARS WITH APPLICATION OF CHITOSAN | 2010 |
|
RU2424812C1 |
METHOD OF TREATING PATHOLOGICAL CICATRICAL SKIN DEFORMITIES | 2015 |
|
RU2599868C1 |
ANTI-CICATRIX CREAM | 2004 |
|
RU2290919C2 |
METHOD FOR REHABILITATION IN BURNT PATIENTS | 2004 |
|
RU2266094C1 |
PREPARATION FOR TREATING POSTOPERATIONAL ADHESIONS IN ORGANS OF ABDOMINAL CAVITY | 2004 |
|
RU2282454C2 |
PHARMACEUTICAL COMPOSITION FOR LOCAL AND EXTERNAL APPLICATION WHEN TREATING TRAUMATIC AND POST-OPERATION INJURIES OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2369387C2 |
GEL FOR TREATMENT, PREVENTION OF FORMATION OF KELOID AND HYPERTROPHIC SKIN CICATRICES AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2377975C2 |
Authors
Dates
1994-01-15—Published
1992-06-16—Filed